{"url_path":"/sec/silo/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 UNREGISTERED SALES OF EQUITY SECURITIES","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1514183/0001213900-26-056079-index.html","accession_number":"0001213900-26-056079","cik":"0001514183","ticker":"SILO","issuer_name":"Silo Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1514183/0001213900-26-056079-index.html","primary_entity_key":"0001514183","primary_entity_name":"Silo Pharma, Inc."},"word_count":39,"has_tables":true,"body_markdown":"**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES\nAND USE OF PROCEEDS**\n\n \n\n \n**(a)**\n**Recent Sales of Unregistered Securities**\n\n \n\nNone.\n\n \n\n \n**(b)**\n**Issuer Purchases of Equity Securities.**\n\n ** **\n\nWe did not repurchase any common stock during\nthe quarterly period ended March 31, 2026."}